Log In
BCIQ
Print this Print this
 

Guanabenz

  Manage Alerts
Collapse Summary General Information
Company AcurePharma AB
DescriptionReduces inflammation by blocking cyclooxygenase (COX), lipoxygenase and nitric oxide synthase (NOS) enzymes
Molecular Target Cyclooxygenases (COX)
Mechanism of ActionCyclooxygenase (COX) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSpinal cord injury (SCI)
Indication DetailsTreat spinal cord injury (SCI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today